I'm the Co-Founder & CEO of Ostro. I've invested in 20+ companies, focusing primarily on healthcare, life science, and enterprise. Previously, I was the Co-Founder of Parsable, which raised $130 million+ from top Silicon Valley funds to develop the Connected Worker platform.
Vertex Is Writing A New Playbook For Pharma R&D. And It’s Working.
Vertex Pharmaceuticals (NDAQ: VRTX) path to becoming a top 20 pharma company with over a $100 billion market cap has been nothing short of adventurous.
How This CEO Consumerized Cancer Diagnostics Into A $13B Enterprise
A decade ago, Exact Sciences launched Cologuard, impacting the fight against colorectal cancer. Its growth of 7000% is in part due to a focus on consumerization.
A Decade Of Innovation: How This CEO Transformed A Global Pharma Giant
In a decade, Christophe Weber remade Takeda into a global pharma leader, shifting from a fragmented structure to a unified innovator.
Serendipity And Science: Forging Billion-Dollar Oncology Breakthroughs
Through serendipity, science, and rigor, SpringWorks Therapeutics, a targeted oncology company, marks success with the first FDA-approved treatment for Desmoid Tumor.
How this CEO Built A Top 50 Pharma Company Focusing On Culture Day 1
Jazz, a T50 Pharma, and unicorn among unicorns, thrives on a people-first culture. CEO Bruce Cozadd's mission-driven approach led to 11 therapeutics in 20 years.